Evidence map›Paper›PMID 30238399›Full record

ReviewWorld journal of urology2019

Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversion.

Oscar Rodríguez Faba, Mark D Tyson, Walter Artibani, Bernard H Bochner, Fiona Burkhard, Scott M Gilbert, Tilman Kälble, Stephan Madersbacher, Roland Seiler, Ella C Skinner and 5 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Oscar Rodríguez FabaUrological Oncology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, C/Cartagena, 340-350, 08025, Barcelona, Spain. orodriguez@fundacio-puigvert.es.
Mark D TysonDepartment of Urology, Mayo Clinic, Scottsdale, USA.
Walter ArtibaniUrology Clinic, Verona Integrated University Hospital, Verona, Italy.
Bernard H BochnerUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
Fiona BurkhardDepartment of Urology, Inselspital Bern, Bern, Switzerland.
Scott M GilbertDepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
Tilman KälbleUrology and Pediatric Urology Clinic, Klinikum Fulda, Fulda, Germany.
Stephan MadersbacherUrology Department, Kaiser-Franz-Josef Hospital, Vienna, Austria.
Roland SeilerUro-Oncology and Prostate Centre, Department of Urology, Inselspital Bern, Bern, Switzerland.
Ella C SkinnerUrologic Oncology, Department of Urology, Stanford University, Stanford, USA.
George ThalmannUro-Oncology and Prostate Centre, Department of Urology, Inselspital Bern, Bern, Switzerland.
Joachim ThüroffDepartment of Urology, University Clinic Mannheim, Mannheim, Germany.
Peter WiklundDepartment of Urology, Department of Molecular Medicine and Surgery, Karolinska University Hospital, Solna, Sweden.
Richard HautmannDepartment of Urology, University of Ulm, Ulm, Germany.
Joan PalouUrological Oncology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, C/Cartagena, 340-350, 08025, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo provide a comprehensive overview and update of the joint consultation of the International Consultation on Urological Diseases (ICUD) and Société Internationale d'Urologie on Bladder Cancer Urinary Diversion (UD).

methodsA detailed analysis of the literature was conducted reporting on the different modalities of UD. For this updated publication, an exhaustive search was conducted in PubMed for recent relevant papers published between October 2013 and August 2018. Via this search, a total of 438 references were identified and 52 of them were finally eligible for analysis. An international, multidisciplinary expert committee evaluated and graded the data according to the Oxford System of Evidence-based Medicine.

resultsThe incidence of early complications has been reported retrospectively in the range of 20-57%. Unfortunately, only a few randomized controlled studies exist within the field of UD. Consequently, almost all studies used in this report are of level 3-4 evidence including expert opinion based on "first principles" research.

conclusionsComplications rates overall following RC and UD are significant, and when strict reporting criteria are incorporated, they are much higher than previously published. Complications can occur up to 20 years after surgery, emphasizing the need for lifelong follow-up. Progress has been made to prevent complications implementing robotic surgery and fast track protocols. Preoperative patient information, patient selection, surgical techniques, and careful postoperative follow-up are the cornerstones to achieve good results.

Indexed as

Carcinoma, Transitional CellCystectomyHumansMuscle, SmoothNeoplasm InvasivenessPostoperative ComplicationsRobotic Surgical ProceduresUrinary Bladder NeoplasmsUrinary DiversionUrinary Reservoirs, ContinentMIBC and urinary diversionsRadical cystectomy and complicationsUrinary diversion

Identifiers

PMID30238399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.